Share the post "Zydus Lifesciences Shareholding pattern FY(Q3-Dec 2024-2025)"
Shareholding results capture the distribution of ownership in a company as outlined in its financial disclosures. These results indicate the proportion of shares held by different investor categories and can reveal trends in market confidence. By studying shareholding results, investors and analysts can assess the influence of major shareholders on corporate governance and stock price movements. Zydus Lifesciences has released its latest shareholding reports, covering the third quarter and the fiscal year ending on (Q3-Dec 2024-2025).This detailed report examines who owns shares, including Promoters, promoter groups, Foreign investors, public investors, and government entities.
Shareholder Name | Previous Quarter Quantity | Current Quarter Quantity | Previous Quarter Shares(in %) | Current Quarter Shares(in %) | Quarter to Quarter Difference |
---|---|---|---|---|---|
Promoters | 75.45 Cr | 75.45 Cr | 74.98 | 74.98 | 0 |
Public | 25.18 Cr | 25.18 Cr | 6.85 | 6.84 | -0.01 % |
DII | 10.72 Cr | 10.72 Cr | 10.65 | 10.65 | 0 |
FII | 7.57 Cr | 7.58 Cr | 7.52 | 7.53 | +0.01 % |
Government | 600 | 10.07 K | 0 | 0 | 0 |
Promoters shareholding remained stable, at 74.98% in both September 2024- and December 2024-. This indicates that the promoters’ control over the company did not change during this period. The percentage of shares held by the public decreased from 6.85% in September 2024- to 6.84% in December 2024-.This reduction indicates that the public’s stake in the company diminished during this period.DIIs (Domestic Institutional Investors) shareholding remained unchanged at 10.65% from September 2024- to December 2024-. This indicates that domestic institutions maintained their investment level in the company. FIIs (Foreign Institutional Investors): There was a significant increase from 7.52% in September 2024-2025 to 7.53% in December 2024-2025. This suggests that foreign institutions grew their investments 0.010000000000001 in the company during the quarter. During quater from September 2024- to December 2024, Goverenment ownership remained steady at 0%.This indicates that the government’s stake in the company remained consistent during this period.
Below is a detailed table showcasing the public shareholding percentage.
Shareholder Name | Previous Quarter Quantity | Current Quarter Quantity | Previous Quarter Shares (in %) | Current Quarter Shares (in %) | Quarter-to-Quarter Difference (%) |
---|---|---|---|---|---|
Resident Individuals holding nominal share capital up to Rs. 2 lakhs | 4.73 Cr | 4.72 Cr | 4.7 | 4.69 | -0.01 % |
Non Resident Indians (NRIs) | 30.08 Lakh | 28.78 Lakh | 0.3 | 0.29 | -0.01 % |
Bodies Corporate | 64.71 Lakh | 64.97 Lakh | 0.64 | 0.65 | + 0.01 % |
Any Other (specify) | 21.52 Lakh | 21.81 Lakh | 0.21 | 0.22 | + 0.01 % |
HUF | 14.55 Lakh | 14.94 Lakh | 0.14 | 0.15 | + 0.01 % |
Observations show a significant difference of -0.01 % in Resident Individuals holding nominal share capital up to Rs. 2 lakhs’s financial performance between quarters.Observations show a significant difference of -0.01 % in Non Resident Indians (NRIs)’s financial performance between quarters.Leading the way to higher stakeholding, Bodies Corporate has significantly boosted stakeholding by an impressive 0.01 %.Leading the way to higher stakeholding, Any Other (specify) has significantly boosted stakeholding by an impressive 0.01 %.Leading the way to higher stakeholding, HUF has significantly boosted stakeholding by an impressive 0.01 %.
Below is a detailed table presenting the shareholding percentage of DIIs.
Shareholder Name | Previous Quarter Quantity | Current Quarter Quantity | Previous Quarter Shares (in %) | Current Quarter Shares (in %) | Quarter-to-Quarter Difference (%) |
---|---|---|---|---|---|
Mutual Funds/ | 6.61 Cr | 6.36 Cr | 6.57 | 6.32 | -0.25 % |
ICICI Prudential Bluechip Fund | 1.41 Cr | 1.83 Cr | 1.4 | 1.81 | + 0.41 % |
Kotak Flexicap Fund | 1.51 Cr | 1.38 Cr | 1.5 | 1.37 | -0.13 % |
Alternate Investment Funds | 4.85 Lakh | 5.62 Lakh | 0.05 | 0.06 | + 0.01 % |
Insurance Companies | 3.88 Cr | 4.11 Cr | 3.85 | 4.08 | + 0.23 % |
Llife Insurance Corporation of India | 3.11 Cr | 3.55 Cr | 3.09 | 3.53 | + 0.44 % |
Provident Funds/ Pension Funds | 12.33 Lakh | 14.96 Lakh | 0.12 | 0.15 | + 0.03 % |
Mutual Funds/ decreased their stake from 6.32% in the previous quarter to 6.57% in the current quarter.It describes a decrease in stakes over consecutive quarters, specifically by -0.25 %.The latest quarter saw a considerable enhancement in stakeholding for ICICI Prudential Bluechip Fund, reflecting an uptick of 0.41 % in their shares.Kotak Flexicap Fund decreased their stake from 1.37% in the previous quarter to 1.5% in the current quarter.It describes a decrease in stakes over consecutive quarters, specifically by -0.13 %.The latest quarter saw a considerable enhancement in stakeholding for Alternate Investment Funds, reflecting an uptick of 0.01 % in their shares.The latest quarter saw a considerable enhancement in stakeholding for Insurance Companies, reflecting an uptick of 0.23 % in their shares.The latest quarter saw a considerable enhancement in stakeholding for Llife Insurance Corporation of India, reflecting an uptick of 0.44 % in their shares.The latest quarter saw a considerable enhancement in stakeholding for Provident Funds/ Pension Funds, reflecting an uptick of 0.03 % in their shares.
The table below displays the shareholding percentage of FIIs.
Shareholder Name | Previous Quarter Quantity | Current Quarter Quantity | Previous Quarter Shares (in %) | Current Quarter Shares (in %) | Quarter-to-Quarter Difference (%) |
---|---|---|---|---|---|
Foreign Portfolio Investors Category I | 7.35 Cr | 7.33 Cr | 7.3 | 7.29 | -0.01 % |
Foreign Portfolio Investors Category II | 22.09 Lakh | 24.58 Lakh | 0.22 | 0.24 | + 0.02 % |
Stakeholding dwindled by -0.01 % for Foreign Portfolio Investors Category I in comparison to the preceding quarter.During this past quarter, there was a noteworthy upswing in stakeholding for Foreign Portfolio Investors Category II, which experienced a significant increase of 0.02 % .
[my_shortcode1 values=”Zydus Lifesciences”]